ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: SU-OR17

Molecular Mechanisms Underlying Sex-Specific Association of Circulating Transforming Growth Factor Β1 with the Risk of Accelerated Kidney Function Decline

Session Information

Category: Women’s Health and Kidney Diseases

  • 2000 Women’s Health and Kidney Diseases

Authors

  • Norvik, Jon V., Universitetssykehuset Nord-Norge, Tromso, Troms, Norway
  • Enoksen, Inger Therese Tonsberg, UiT Norges arktiske universitet Det helsevitenskapelige fakultet, Tromso, Troms, Norway
  • O'Connor, Christopher Lund, University of Michigan, Ann Arbor, Michigan, United States
  • Solbu, Marit D., Universitetssykehuset Nord-Norge, Tromso, Troms, Norway
  • Nair, Viji, University of Michigan, Ann Arbor, Michigan, United States
  • Kretzler, Matthias, University of Michigan, Ann Arbor, Michigan, United States
  • Ju, Wenjun, University of Michigan, Ann Arbor, Michigan, United States
  • Eriksen, Bjorn Odvar, UiT Norges arktiske universitet Det helsevitenskapelige fakultet, Tromso, Troms, Norway
  • Bitzer, Markus, University of Michigan, Ann Arbor, Michigan, United States
  • Melsom, Toralf, Universitetssykehuset Nord-Norge, Tromso, Troms, Norway
Background

Study of sex differences in kidney function decline and risk of chronic kidney disease (CKD) is a stated research goal. We recently found serum transforming growth factor β1 (TGF-β1), a key mediator in kidney fibrosis development, to be associated with risk of accelerated age-related loss of glomerular filtration rate (GFR) in women, but not men, in the general population. We therefore investigated the effect of sex on intrarenal TGF-β1 pathway and structural damage in kidney biopsies from a cohort of patients with early kidney impairment.

Methods

Kidney tissue samples from 22 female and 33 male patients undergoing nephrectomy included in the PRECISE study (age 31 to 83 years) were used for transcriptomic analysis of micro-dissected glomeruli (Affymetrix Human Gene 2.1 ST Array). Interaction of the expression of genes in the TGF-β1 signaling pathway with sex was evaluated between expression level and global glomerulosclerosis (GGS), a structural parameter of kidney disease. Genes exhibiting significant interaction with sex were used to generate a sex-dependent TGF-β1 pathway activity score.

Results

Out of the 136 genes downstream of TGF-β1, expression of 20 genes exhibited significant interaction with sex for GGS. BMP6, ID1, MYC, and TNF were among the genes that showed the most significant interaction. An increased activity score for sex-specific TGF-β1 downstream effectors was associated with higher degree of GGS in women (p<0.001), but with less GGS in men (p=0.01, p for interaction with sex <0.001, Figure 1).

Conclusion

Higher levels of the sex-specific TGF-β1 pathway activity was associated with higher GGS in women, but with less GGS in men. These results, along with our findings of an association between higher serum TGF-β1 and accelerated GFR decline in women only, point to a sex-specific TGF-β1 driven mechanism of kidney fibrosis that may shed light on sex differences in age-related GFR loss and CKD.

Figure 1